- Home
- NTIP vs PLUR Comparison
NTIP vs PLUR Comparison
Compare NTIP & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIP
- PLUR
- Stock Information
- Founded
- NTIP 1990
- PLUR 2001
- Country
- NTIP United States
- PLUR Israel
- Employees
- NTIP N/A
- PLUR N/A
- Industry
- NTIP Multi-Sector Companies
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTIP Miscellaneous
- PLUR Health Care
- Exchange
- NTIP Nasdaq
- PLUR Nasdaq
- Market Cap
- NTIP 30.8M
- PLUR 30.2M
- IPO Year
- NTIP 1998
- PLUR N/A
- Fundamental
- Price
- NTIP $1.29
- PLUR $4.56
- Analyst Decision
- NTIP
- PLUR
- Analyst Count
- NTIP 0
- PLUR 0
- Target Price
- NTIP N/A
- PLUR N/A
- AVG Volume (30 Days)
- NTIP 43.4K
- PLUR 16.2K
- Earning Date
- NTIP 10-31-2024
- PLUR 11-11-2024
- Dividend Yield
- NTIP 7.94%
- PLUR N/A
- EPS Growth
- NTIP N/A
- PLUR N/A
- EPS
- NTIP N/A
- PLUR N/A
- Revenue
- NTIP $1,881,000.00
- PLUR $326,000.00
- Revenue This Year
- NTIP N/A
- PLUR N/A
- Revenue Next Year
- NTIP N/A
- PLUR N/A
- P/E Ratio
- NTIP N/A
- PLUR N/A
- Revenue Growth
- NTIP 129.39
- PLUR 13.59
- 52 Week Low
- NTIP $1.24
- PLUR $3.44
- 52 Week High
- NTIP $2.25
- PLUR $8.48
- Technical
- Relative Strength Index (RSI)
- NTIP 35.12
- PLUR 38.06
- Support Level
- NTIP $1.24
- PLUR $4.54
- Resistance Level
- NTIP $1.39
- PLUR $4.91
- Average True Range (ATR)
- NTIP 0.06
- PLUR 0.36
- MACD
- NTIP -0.00
- PLUR -0.05
- Stochastic Oscillator
- NTIP 9.52
- PLUR 6.52
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility.